Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hanefeld

Showing results (31-40 of 224) with videos related to

Pageof 23
Sort By:
Therapeutische Umschau. Revue Therapeutique|December 1, 1996
[Rational therapy of Type II diabetes]M Hanefeld, S Fischer
Der Internist|July 1, 1996
[Metabolic syndrome]M Hanefeld, P Scriba
MMW Fortschritte Der Medizin|April 2, 2003
[Therapy decision based on the glucose triad. Drug treatment of type 2 diabetes]M Hanefeld, S Fischer
Zeitschrift Fur Lebensmittel-Untersuchung Und -Forschung|January 1, 1976
[On the occurrence of proanthocyanidins, leucoanthocyanidins and catechins in vegetables (author's transl)]M Hanefeld, K Herrmann
The Journal of International Medical Research|October 26, 2001
Effect of the angiotensin II receptor antagonist valsartan on lipid profile and glucose metabolism in patients with hypertensionM Hanefeld, C Abletshauser
Therapeutische Umschau. Revue Therapeutique|September 19, 2002
[Differential type 2 diabetes therapy based on pathophysiological aspects]M Hanefeld, S Fischer
Der Internist|July 1, 1996
[Diagnosis of the metabolic syndrome]M Hanefeld, B Willms
Przeglad Lekarski|January 1, 1989
Hypertriglyceridemia--independent risk factor or risk marker?M Hanefeld, K Lüthke
Diabetic Medicine : a Journal of the British Diabetic Association|August 14, 1998
Commercially sponsored supplementsM Hanefeld, T Temelkova-Kurktschiev
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|August 23, 2002
Control of post-prandial hyperglycemia--an essential part of good diabetes treatment and prevention of cardiovascular complicationsM Hanefeld, T Temelkova-Kurktschiev
Pageof 23

Showing results (31-40 of 224) with videos related to

Sort By:
Pageof 23
Therapeutische Umschau. Revue Therapeutique|December 1, 1996
[Rational therapy of Type II diabetes]M Hanefeld, S Fischer
Der Internist|July 1, 1996
[Metabolic syndrome]M Hanefeld, P Scriba
MMW Fortschritte Der Medizin|April 2, 2003
[Therapy decision based on the glucose triad. Drug treatment of type 2 diabetes]M Hanefeld, S Fischer
Zeitschrift Fur Lebensmittel-Untersuchung Und -Forschung|January 1, 1976
[On the occurrence of proanthocyanidins, leucoanthocyanidins and catechins in vegetables (author's transl)]M Hanefeld, K Herrmann
The Journal of International Medical Research|October 26, 2001
Effect of the angiotensin II receptor antagonist valsartan on lipid profile and glucose metabolism in patients with hypertensionM Hanefeld, C Abletshauser
Therapeutische Umschau. Revue Therapeutique|September 19, 2002
[Differential type 2 diabetes therapy based on pathophysiological aspects]M Hanefeld, S Fischer
Der Internist|July 1, 1996
[Diagnosis of the metabolic syndrome]M Hanefeld, B Willms
Przeglad Lekarski|January 1, 1989
Hypertriglyceridemia--independent risk factor or risk marker?M Hanefeld, K Lüthke
Diabetic Medicine : a Journal of the British Diabetic Association|August 14, 1998
Commercially sponsored supplementsM Hanefeld, T Temelkova-Kurktschiev
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|August 23, 2002
Control of post-prandial hyperglycemia--an essential part of good diabetes treatment and prevention of cardiovascular complicationsM Hanefeld, T Temelkova-Kurktschiev
Pageof 23